Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Piramal Pharma Limited ( (IN:PPLPHARMA) ) is now available.
Piramal Pharma Limited announced the completion of a significant financial transaction involving its subsidiary, Piramal Healthcare Inc., which subscribed to 1,903 optionally convertible redeemable preference shares of PPL Pharma Inc., valued at USD 190.3 million. This strategic move is expected to enhance the company’s financial structure and strengthen its market position, potentially impacting stakeholders positively by increasing the company’s operational capabilities.
More about Piramal Pharma Limited
Piramal Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is involved in providing a range of services and products, including critical care, consumer products, and contract development and manufacturing services, catering to a global market.
Average Trading Volume: 222,462
Technical Sentiment Signal: Hold
Current Market Cap: 256.5B INR
For a thorough assessment of PPLPHARMA stock, go to TipRanks’ Stock Analysis page.